controlled trial · 2020
“Furthermore, such extra-intestinal symptoms as fatigue and weakness (P = 0.000), musculo-skeletal pain (P = 0.000) and headache (P = 0.002) improved in NCGS patients on GFD.”
Prevalence of Non-Celiac Gluten Sensitivity in Patients with Refractory Functional Dyspepsia: a Randomized Double-blind Placebo Controlled Trial. Sci Rep
Who: 77 Iranian adults aged 18-55 with refractory functional dyspepsia, celiac disease, wheat allergy and H. pylori excluded; 27 gluten-free-diet responders entered the blinded challenge
PMID 32051513